Co-Authors
This is a "connection" page, showing publications co-authored by Giancarlo Ceccarelli and Mario Venditti.
Connection Strength
4.999
-
The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study). J Med Virol. 2021 Jul; 93(7):4319-4325.
Score: 0.936
-
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. Eur J Clin Invest. 2021 Jan; 51(1):e13418.
Score: 0.908
-
Follow-up Blood Cultures: A 2.0 Diagnostic Tool in Patients With Gram-Negative Bacteremia and Septic Thrombophlebitis. Clin Infect Dis. 2018 03 19; 66(7):1154-1155.
Score: 0.760
-
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2022 Feb; 50(1):83-92.
Score: 0.238
-
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study. Front Nutr. 2020; 7:613928.
Score: 0.231
-
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization. Infez Med. 2020 Dec 01; 28(4):534-538.
Score: 0.229
-
Is teicoplanin a complementary treatment option for COVID-19? The question remains. Int J Antimicrob Agents. 2020 Aug; 56(2):106029.
Score: 0.221
-
Procalcitonin as guide to therapy in endovascular infections: caveat emptor! Clin Chem Lab Med. 2019 03 26; 57(4):e52-e53.
Score: 0.204
-
Correction to: A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam. Infection. 2018 10; 46(5):743.
Score: 0.197
-
Specific dynamic of serum procalcitonin in critically ill patients affected by Gram-negative bacilli septic thrombophlebitis. Crit Care. 2018 07 23; 22(1):178.
Score: 0.194
-
A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam. Infection. 2018 Oct; 46(5):721-724.
Score: 0.193
-
Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients. Antimicrob Agents Chemother. 2018 06; 62(6).
Score: 0.192
-
Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation. Mycoses. 2017 Dec; 60(12):826-829.
Score: 0.183
-
Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report. Thromb Haemost. 2021 01; 121(1):102-105.
Score: 0.058
-
Nox2 activation in Covid-19. Redox Biol. 2020 09; 36:101655.
Score: 0.056
-
Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19. Circ Res. 2020 07 17; 127(3):400-401.
Score: 0.055
-
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study. J Infect. 2019 08; 79(2):130-138.
Score: 0.052
-
Fast and reliable diagnosis of XDR Acinetobacter baumannii meningitis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. New Microbiol. 2018 Jan; 41(1):77-79.
Score: 0.046
-
A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients. Clinicoecon Outcomes Res. 2017; 9:385-390.
Score: 0.045